The neuropathology of schizophrenia

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 7, 1999, Pages 679-690

  Powers, Richard E ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Bureau of Geriatric Psychiatry   (United States)

Author keywords

Autopsy; Brain imaging; Development; Genetics; Histopathology; Neurochemistry; Psychosis

Indexed keywords

ANATOMICAL VARIATION; BRAIN REGION; CHILDHOOD INJURY; CLINICAL FEATURE; FUNCTIONAL ANATOMY; GENETIC SUSCEPTIBILITY; HUMAN; MYELINATION; NEUROCHEMISTRY; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPTOGENESIS;

EID: 0032800280     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199907000-00001     Document Type: Review

References (98)

1. Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry/ v, Baltimore: Williams & Wilkins, 1989
2. Roberts GW, Leigh PN, Weinberger DR. In: Neuropsychiatric disorders. St. Louis: Wolfe, 1993;14.1-41.18
3. Andreasen NC. The American concept of schizophrenia. Schizophr Bull 1989;15:519-31
4. Eisenburg L. The social construction of the human brain. Am J Psychiatry 1995;152:1563-75
5. Levine JM. The legacy of Philippe Pinel. JAGS 1996;44:1130-33
6. Kandel, ER. A new intellectual framework for psychiatry. Am J Psychiatry 1998;155:457-69
7. Heckers S. Neuropathology of schizophrenia: Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 1997;23:403-21
8. Salzman S, Endicott J, Clayton P, Winokur G. Diagnostic evaluation after death (DEAD). Rockville, MD, National Institute of Mental Health, Neuroscience Research Branch, 1983
9. Hill C, Keks N, Roberts S, et al. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996;153:533-37
10. Diagnostic and statistical manual of mental disorders, 4th ed., Washington DC: American Psychiatric Association, 1994
11. Silbersweig DA, Stern E, Frith C, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176-79
12. Kendler KS, Karkowski LM, Walsh D. The structure of psychosis. Arch Gen Psychiatry 1998;55:492-99
13. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-7
14. Kremen WS, Buka SL, Seidman LJ, Goldstein JM, Koren D, Tsuang MT. Decline during childhood and adult psychotic symptoms in a community sample: A 19-year longitudinal study. Am J Psychiatry 1998;155:672-77
15. Pritchard PB, Lombroso CT, McIntyre M. Psychological complications of temporal lobe epilepsy. Neurology 1980;30:227-32
16. Sachdev P. Schizophrenia-like psychosis and epilepsy: The status of the association. Am J Psychiatry 1998;155:325-36
17. Roberts GW, Done DJ, Bruton C, Crow TJ. A "mock up" of schizophrenia: Temporal lobe epilepsy and schizophrenia-like psychosis. Biol Psychiatry 1990;28:127-43
18. Arndt, S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia: Predictions and patterns of change. Arch Gen Psychiatry 1995;52:352-60
19. Sabri O, Erkwoh R, Schreckenberger M, Owega A, Sass H, Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997;349:1735-39
20. Assad G, Shapiro B. Hallucinations: Theoretical and clinical overview. Am J. Psychiatry 1986;143:1088-97
21. Penfield W, Perot P. The brain's record of auditory and visual experience. Brain 1963;86:595-705
22. Cummings JL. Organic delusions. Br J Psychiatry 1985;146:184-97
23. Andreasen NC, O'Leary DS, Flaum M, et al. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 1997;349:1730-34
24. Ismail B, Cantor-Graae EC, McNeil TF. Nuerological abnormalities in schizophrenic patients and their siblings. Am J Psychiatry 1998;155:84-89
25. Blackwood DH, St. Clair DM, Muir WJ, Duffy JC. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry 1991;48:899-909
26. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J. Psychiatry 1994;151:1409-16
27. Jones PB, Rantakallio P, Hartikiainen AL, Isohanni M, Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: A 28 year follow-up of the 1996 North Finland general population birth cohort. Am J Psychiatry 1998;155: 355-64
28. Cantor-Graae E, McNeil TF, Sjostrom K, Nordstrom LG, Rosenlund T. Maternal demographis correlates of increased history of obstetric complications in schizophrenia. J Psychiatry Res 1997;31:347
29. Levinson DF, Mahtani MM, Nancarrow DJ, et al. Genome scan of schizophrenia. Am J Psychiatry 1998;155:741-50
30. Jeste DV. Medical comorbidity in schizophrenia. Schizophr Bull 1996;22:413-30
31. Carlsson A, Hanson LO, Waters N, Carlsson ML. Neurotransmitters aberrations in schizophrenia: New perspectives and therapeutic implications. Life Sciences 1997;61:75-94
32. Deakin JF, Simpson MD. A two-process theory of schizophrenia: Evidence from studies in post-mortem brain. J. Psychiatry Res 1997;31:277-95
33. Joyce JN, Goldsmith SG, Gurevich EV. Limbic circuits and monoamine receptors: Dissecting the effects of antipsychotics from disease processes. J Psychiatry Res 1997;31:197-217
34. Lewis DA, Akil M. Cortical dopamine in schizophrenia: Strategies for postmortem studies. J Psychiatry Res 1997;31:175-95
35. Gjedde A, Reith J, Wong DF. Letter to editor. Psychiatry Res 1996;67:159-62
36. Jones EG. Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997;23:483-501
37. Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine Dl receptors in schizophrenia revealed by PET. Letters to Nature 1996:634-36
38. Lewis DA. Neural circuitry of the prefrontal cortex I schizophrenia. Arch Gen Psychiatry 1995;52:269-73
39. Sanyal S, Van Tol HH. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatry Res 1997;31:219
40. Chakos MH, Lieberman JA, Bilder RM, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994;151:1430-36
41. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet 1994;344:1434-35
42. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am J Psychiatry 1998;155:774-78
43. Roberts RC, Gaither LA, Gao S, Kashyap SM, Tamminga CA. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse 1995;20:234-43
44. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han L, Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 1998;55:225-32
45. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davis KL. Alzheimer's disease and related neurodegenerative diseases in elderly patients with schizophrenia. Arch Gen Psychiatry 1998;55:205-11
46. Bloom FE. Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 1993;50:224-27
47. Bunney BG, Potkin SG. Bunney WE. Neuropathological studies of brain tissue in schizophrenia. J. Psychiatry Res 1997;31:159-73
48. Weikert CS, Weinberger DR. A candidate molecule approach to defining developmental pathology in schizophrenia. Schizophr Bull 1998;24:303-16
49. Lim KO, Adalsteinsson E, Speilman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998;55:346-52
50. Zipursky RB, Lambe EK, Kapur S, Mikulis DK. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry 1998;55:540-46
51. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. Schizophrenia and the brain: A prospective clinico-neuropathological study. Psychol Med 1990;20:285-304
52. Bilder RM, Wu H, Bogerts B, et al. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994;151:1437-47
53. Jacobsen LK, Giedd JN, Castellanos FX, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998;155:678-85
54. Gur RE, Cowell P, Turetsky BI, Gallacher F, et al. A followup magnetic resonance imaging study of schizophrenia: Relationship of neuronanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998;55:145
55. Barta PE, Petty RG, McGilchrist L, et al. Asymmetry of the planum temporale; methodological considerations and clinical associations. Psychiatry Res 1995;61:137-50
56. Galaburda AM, Sanides F, Geschwind N. Human brain: Cytoarchitectonic left-right asymmetries in the temporal speech region. Arch Neurol 1978;35:812-17
57. Delisi LE, Sakuma M, Kushner M, Finer DL, Hoff AL Crow TJ. Anamalous cerebral asymmetry and language processing in schizophrenia. Schizophr Bull 1997;23:255-71
58. Petty RG, Barta PE, Pearlson GD, et al. Reversal of asymmetry of the planum temporale in Schizophrenia. Am J Psychiatry 1995;152: 715-21
59. Kikinis, R, Shenton ME, Guido G, et al. Temporal lobe sulco-gyral pattern anomalies in schizophrenia: An in vivo MR three-dimensional surface rendering study. Neurosci Lett 1994;182:7-12
60. Barta PE, Pearlson GD. Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990;147:1457-62
61. Tune L, Barta P, Wong D, et al. Striatal dopamine D2 receptor quantification and superior temporal gyrus: Volume determination in 14 chronic schizophrenic subjects. Psychiatry Res 1996;67:155-62
62. McCarley RW, Faux SF, Shenton M, et al. CT abnormalities in schizophrenia. Arch Gen Psychiatry 1989;46:698-708
63. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE, Jones EG. Distorted distribution of nicotinamide-adeine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993;50:178-87
64. Goldsmith SK, Shapiro RM, Joyce JN. Disrupted patteren of D2 dopamine receptors in the temporal lobe in schizophrenia. Arch Gen Psychiatry 1997;54:649-58
65. Dwork AJ. Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull 1997;23:385-402
66. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study. Arch Gen Psychiatry 1998;55:433-40
67. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990;322:789-94
68. Bogerts B, Falkai P, Haupts M, et al. Postmortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 1990;3:295-301
69. Bogerts B, Lieberman JA, Ashtari M, et al. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 1993;33:236-46
70. Arnold SE, Fanz BR, Gur RC, et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interation. Am J Psychiatry 1995;152:738-47
71. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry 1989;46: 1019-24
72. Heckers S, Heinsen H, Heinsen YC, Beckman H. Morphometry of the parahippocampal gyrus in schizophrenics and controls. Some anatomical considerations. J Neural Transm (General Section) 1990;80:151-55
73. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991;48:413-17
74. Christison GW, Casanova MF, Weinberger DR, Rawlings R, Kleinman JE. Quantitative investigations of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 1989;46:1027-32
75. Arnold SE, Lee VA, Gur RE, Trojanowski JQ. Abnormal expression of two microbubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991b;88:10850-54
76. Rosoklija G, Hays AP, Latov N, et al. Loss of subicular MAP2 immunoreactivity in psychiatric disorders. (Abstract) Society for Neuroscience Abstracts 1996;22:731
77. Jakob H, Beckmann H. Gross and histological criteria for developmental disorders in brains of schizophrenics. J Royal Soc Med 1989;82:466-69
78. Arnold SE, Hyman BT, Van Hosesen GW, Damaslo AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625-32
79. Brown R, Colter N, Corsellis JA, et al. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry 1986;43:36-42
80. Wible CG, Shenton ME, Kikinis R, et al. Prefrontal cortex and schizophrenia. Arch Gen Psychiatry 1995;52:279-88
81. Bertolino A, Nawroz S, Mattay VS, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996;153:1554-63
82. Pettegrew JW, Keshavan MS, Minshew NJ. 31P nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia. Schizophr Bull 1993;19:35-53
83. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry 1995;52:805-187
84. Rajowska G, Selemon LD, Rakic PS. Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998;55:215
85. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996;53:425-36
86. Akbarian SK, Bunney WE, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52: 258-66
87. Lee DE. Reduced inhibitory capacity in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52:267-68
88. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 1997;54:660-69
89. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RS, Grasby PM. Dopaminergic modulation of impaired cognitive activcation in the anterior cingulate cortex in schizophrenia. Nature 1995;378: 180-82
90. Benes FM. Postmortem schizophrenic brain. Schizophr Bull 1998;24:224-30
91. Honer WG, Falkai P, Young C, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997;78:99-110
92. Buchsbaum MS, Potkin SG, Siegel BV, et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992;49:966-74
93. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991;48:881-90
94. Shihabuddin L, Buchsbaum MS, Hazlett EA, et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 1998;55:235-43
95. Buchsbaum MS, Someya T, Teng CY, et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996;153:191-99
96. Alyward EH, Reiss A, Barta PE, et al. Magnetic resonance imaging measurement of posterior fossa structures in schizophrenia. Am J Psychiatry 1994;151:1448-52
97. Katsetos CD, Hyde TM, Herman MM. Neuropathology of the cerebellum in schizophrenia - An update: 1996 and future directions. Biol Psychiatry 1997;42:213-24
98. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am J Psychiatry 1997;154:861-63